Kidney Disease Clinical Trials in Chicago

Showing 121-140 of 484 trials

Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.

NCT06374537

This research is being done to better understand the impact of the use of a specific physical activity training program (GH Method) in dialysis/kidney disease patients.

FrailtyPain, ChronicDialysis; Complications+1 more

University of Illinois at Chicago150 participantsStarted May 2019

Chicago, Illinois, United States

COMPLETEDPhase 22.2 miles

Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease

NCT05514548

The study is designed to assess the efficacy, safety, tolerability, and transformation within the human body of INV-202 investigational drug in the treatment of adult participants with a diagnosis of Diabetic Kidney Disease due to either Type 1 diabetes mellitus or Type 2 diabetes mellitus.

Diabetic Kidney Disease

Inversago Pharma Inc.265 participantsStarted Oct 2022

Garden Grove, California, United States • Pomona, California, United States • Salinas, California, United States +69 more locations

Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.

Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease

Kidney Disease Trials in Other Cities

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis

Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)

Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease

Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)

Evaluation of Gadoterate in Patients With Renal Dysfunction

Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)

A Study of Renal Microvessel Imaging for Chronic Kidney Disease

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004).

A Study to Evaluate the Pharmacokinetics and Safety of INCB054707 in Participants With Normal Hepatic Function and Participants With Hepatic Impairment

Other Conditions in Chicago